oncology nursing
TRANSCRIPT
![Page 1: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/1.jpg)
OncologyOncology
By:By:
Ruby Ruth T. Roces, R.N., M.D.Ruby Ruth T. Roces, R.N., M.D.
![Page 2: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/2.jpg)
Oncology definedOncology defined
It is a branch of medicine that It is a branch of medicine that deals with the study, detection, deals with the study, detection, treatment and management of treatment and management of cancer cancer
![Page 3: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/3.jpg)
glossaryglossary
Neoplasia-uncontrolled cell growth that Neoplasia-uncontrolled cell growth that follows no physiologic demandfollows no physiologic demand
Anaplasia-cells that lack normal cellular Anaplasia-cells that lack normal cellular characteristics and differ in shape and characteristics and differ in shape and organizationorganization
Metaplasia-conversion of one type of Metaplasia-conversion of one type of mature cell into another; reversiblemature cell into another; reversible
![Page 4: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/4.jpg)
Dysplasia-bizarre cell growth resulting in Dysplasia-bizarre cell growth resulting in cells that differ in size, shape or cells that differ in size, shape or arrangement from other cells of the same arrangement from other cells of the same type.type.
Hypoplasia-incomplete or Hypoplasia-incomplete or underdevelopment w/ decreased number underdevelopment w/ decreased number of cellsof cells
![Page 5: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/5.jpg)
Hyperplasia-Increase in the number of Hyperplasia-Increase in the number of cellscells
Hypotrophy-decrease in the organ size Hypotrophy-decrease in the organ size /function /function
Hypertrophy-increase in the sizeHypertrophy-increase in the size
![Page 6: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/6.jpg)
““Root words”Root words”
A- noneA- none Ana- lackAna- lack Hyper- excessiveHyper- excessive Meta- changeMeta- change Dys- bad, derangedDys- bad, deranged
![Page 7: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/7.jpg)
Classification of NeoplasiaClassification of Neoplasia
1. Benign1. Benign
2. Malignant2. Malignant
3. Borderline/ in situ3. Borderline/ in situ
![Page 8: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/8.jpg)
WAYS TO DIFFERENTIATE A BENIGN WAYS TO DIFFERENTIATE A BENIGN FROM A MALIGNANT TUMORFROM A MALIGNANT TUMOR
metastaticNon metastaticMetastases
Invasive, expansive,infiltrating, destructive, w/ generalized effects
Local invasion, encapsulated, local effects
Local invasion
Poorly differentiatedWell differentiatedDifferentiation
Varies, but usually fast-growingSlow- growingRate of growth
MalignantBenignCharacteristics
![Page 9: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/9.jpg)
![Page 10: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/10.jpg)
Nomenclature of NeoplasiaNomenclature of Neoplasia
Tumor is named according to:Tumor is named according to:
1. Parenchyma, Organ or Cell1. Parenchyma, Organ or Cell Hepatoma- liverHepatoma- liver Osteoma- boneOsteoma- bone Myoma- muscleMyoma- muscle
![Page 11: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/11.jpg)
Nomenclature of NeoplasiaNomenclature of Neoplasia
Tumor is named according to:Tumor is named according to:
2. Pattern and Structure, either GROSS or 2. Pattern and Structure, either GROSS or MICROSCOPICMICROSCOPIC
Fluid-filledFluid-filled CYST CYST GlandularGlandular ADENO ADENO Finger-likeFinger-like PAPILLO PAPILLO StalkStalk POLYP POLYP
![Page 12: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/12.jpg)
Nomenclature of NeoplasiaNomenclature of Neoplasia
Tumor is named according to:Tumor is named according to:
3. Embryonic origin3. Embryonic origin Ectoderm ( usually gives rise to epithelium)Ectoderm ( usually gives rise to epithelium) Endoderm (usually gives rise to glands)Endoderm (usually gives rise to glands) Mesoderm (usually gives rise to Connective Mesoderm (usually gives rise to Connective
tissues)tissues)
![Page 13: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/13.jpg)
BENIGN TUMORSBENIGN TUMORS
Suffix- “OMA” is usedSuffix- “OMA” is used Adipose tissue- LipOMAAdipose tissue- LipOMA Bone- osteOMABone- osteOMA Muscle- myOMAMuscle- myOMA Blood vessels- angiOMABlood vessels- angiOMA Fibrous tissue- fibrOMAFibrous tissue- fibrOMA
![Page 14: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/14.jpg)
MALIGNANT TUMORMALIGNANT TUMOR
Named according to embryonic cell originNamed according to embryonic cell origin
1. Ectodermal, Endodermal, Glandular, 1. Ectodermal, Endodermal, Glandular, EpithelialEpithelial
Use the suffix- “CARCINOMA”Use the suffix- “CARCINOMA” Pancreatic AdenoCarcinomaPancreatic AdenoCarcinoma Squamos cell CarcinomaSquamos cell Carcinoma
![Page 15: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/15.jpg)
MALIGNANT TUMORMALIGNANT TUMOR
Named according to embryonic cell originNamed according to embryonic cell origin
2. Mesodermal, connective tissue origin2. Mesodermal, connective tissue origin Use the suffix “SARCOMAUse the suffix “SARCOMA FibroSarcomaFibroSarcoma MyosarcomaMyosarcoma AngioSarcomaAngioSarcoma
![Page 16: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/16.jpg)
““Exceptionistas”Exceptionistas”
1. “OMA” but Malignant1. “OMA” but Malignant HepatOMA, lymphOMA, gliOMA, melanOMAHepatOMA, lymphOMA, gliOMA, melanOMA
2. THREE germ layers2. THREE germ layers ““TERATOMA”TERATOMA”
3. Non-neoplastic but “OMA”3. Non-neoplastic but “OMA” ChoristomaChoristoma HamatomaHamatoma
![Page 17: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/17.jpg)
CANCER NURSINGCANCER NURSING
Review of Normal Cell CycleReview of Normal Cell Cycle
3 types of cells3 types of cells
1. PERMANENT cells- out of the cell cycle1. PERMANENT cells- out of the cell cycle Neurons, cardiac muscle cellNeurons, cardiac muscle cell
2. STABLE cells- Dormant/Resting (G0)2. STABLE cells- Dormant/Resting (G0) Liver, kidneyLiver, kidney
3. LABILE cells- continuously dividing3. LABILE cells- continuously dividing GIT cells, Skin, endometrium , Blood cellsGIT cells, Skin, endometrium , Blood cells
![Page 18: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/18.jpg)
CANCER NURSINGCANCER NURSING
Cell CycleCell CycleG0------------------G1G0------------------G1SSG2G2MM G0- Dormant or restingG0- Dormant or resting G1- normal cell activitiesG1- normal cell activities S- DNA SynthesisS- DNA Synthesis G2- pre-mitotic, synthesis of proteins for G2- pre-mitotic, synthesis of proteins for
cellular divisioncellular division M- Mitotic phase (I-P-M-A-T)M- Mitotic phase (I-P-M-A-T)
![Page 19: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/19.jpg)
CANCER NURSINGCANCER NURSING
Theories to the Pathogenesis of CancerTheories to the Pathogenesis of Cancer Cellular transformation and derangement Cellular transformation and derangement
theorytheory Immune response failure theoryImmune response failure theory
![Page 20: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/20.jpg)
CANCER NURSINGCANCER NURSING
Etiology of cancerEtiology of cancer
1. PHYSICAL AGENTS1. PHYSICAL AGENTS Radiation (thyroid CA)Radiation (thyroid CA) Exposure to irritants (skin CA)Exposure to irritants (skin CA) Exposure to sunlight (skin CA)Exposure to sunlight (skin CA)
![Page 21: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/21.jpg)
CANCER NURSINGCANCER NURSING
Etiology of cancerEtiology of cancer
2. CHEMICAL AGENTS2. CHEMICAL AGENTS Smoking (Lung CA)Smoking (Lung CA) Dietary ingredients (gastric CA)Dietary ingredients (gastric CA) DrugsDrugs
![Page 22: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/22.jpg)
CANCER NURSINGCANCER NURSING
Etiology of cancerEtiology of cancer
3. Genetics and Family History3. Genetics and Family History Colon CancerColon Cancer Breast cancerBreast cancer
![Page 23: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/23.jpg)
CANCER NURSINGCANCER NURSING
Etiology of cancerEtiology of cancer
4. Dietary Habits4. Dietary Habits Low-FiberLow-Fiber High-fatHigh-fat Processed foodsProcessed foods alcoholalcohol
![Page 24: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/24.jpg)
CANCER NURSINGCANCER NURSING
Etiology of cancerEtiology of cancer
5. Viruses and Bacteria5. Viruses and Bacteria DNA viruses- HepaB, Herpes, EBV, CMV, DNA viruses- HepaB, Herpes, EBV, CMV,
Papilloma VirusPapilloma Virus RNA Viruses- HIV, HTCLVRNA Viruses- HIV, HTCLV Bacterium- H. pyloriBacterium- H. pylori
![Page 25: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/25.jpg)
CANCER NURSINGCANCER NURSING
Etiology of cancerEtiology of cancer 6. Hormonal agents6. Hormonal agents DESDES OCP especially estrogen OCP especially estrogen
![Page 26: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/26.jpg)
CANCER NURSINGCANCER NURSING
Etiology of cancerEtiology of cancer 7. Immune Disease7. Immune Disease AIDSAIDS
![Page 27: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/27.jpg)
CANCER NURSINGCANCER NURSING
CARCINOGENSISCARCINOGENSIS Malignant transformationMalignant transformation IIPPPP InitiationInitiation PromotionPromotion ProgressionProgression
![Page 28: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/28.jpg)
CANCER NURSINGCANCER NURSING
CARCINOGENSISCARCINOGENSIS INITIATIONINITIATION Carcinogens alter the DNA of the cellCarcinogens alter the DNA of the cell Cell will either die or repairCell will either die or repair
![Page 29: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/29.jpg)
CANCER NURSINGCANCER NURSING
CARCINOGENSISCARCINOGENSIS PROMOTIONPROMOTION Repeated exposure to carcinogensRepeated exposure to carcinogens Abnormal gene will expressAbnormal gene will express Latent periodLatent period
![Page 30: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/30.jpg)
CANCER NURSINGCANCER NURSING
CARCINOGENSISCARCINOGENSIS PROGRESSIONPROGRESSION Irreversible periodIrreversible period Cells undergo NEOPLASTIC transformation Cells undergo NEOPLASTIC transformation
then malignancythen malignancy
![Page 31: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/31.jpg)
CANCER NURSINGCANCER NURSING
Spread of CancerSpread of Cancer 1. LYMPHATIC1. LYMPHATIC
Most commonMost common
2. HEMATOGENOUS2. HEMATOGENOUS Blood-borne, commonly to Liver and LungsBlood-borne, commonly to Liver and Lungs
3. DIRECT INVASION/EXTENSION3. DIRECT INVASION/EXTENSION Seeding of tumorsSeeding of tumors
![Page 32: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/32.jpg)
![Page 33: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/33.jpg)
CANCER NURSINGCANCER NURSING
Body Defenses Against TUMORBody Defenses Against TUMOR 1. T cell System/ Cellular Immunity1. T cell System/ Cellular Immunity
Cytotoxic T cells kill tumor cellsCytotoxic T cells kill tumor cells 2. B cell System/ Humoral immunity2. B cell System/ Humoral immunity
B cells can produce antibodyB cells can produce antibody 3. Phagocytic cells3. Phagocytic cells
Macrophages can engulf cancer cell debrisMacrophages can engulf cancer cell debris
![Page 34: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/34.jpg)
CANCER NURSINGCANCER NURSING
Cancer DiagnosisCancer Diagnosis 1. BIOPSY 1. BIOPSY
The most definitiveThe most definitive 2. CT, MRI- for visualization and staging2. CT, MRI- for visualization and staging 3. Tumor Markers3. Tumor Markers
![Page 35: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/35.jpg)
CANCER NURSINGCANCER NURSING
Cancer Grading Cancer Grading
The degree of DIFFERENTIATIONThe degree of DIFFERENTIATION Grade 1- Low gradeGrade 1- Low grade Grade 4- high gradeGrade 4- high grade
![Page 36: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/36.jpg)
CANCER NURSINGCANCER NURSING
Cancer StagingCancer Staging
1. Uses the T-N-M staging system1. Uses the T-N-M staging system T- tumorT- tumor N- NodeN- Node M- MetastasisM- Metastasis
2. Stage 1 to Stage 42. Stage 1 to Stage 4
![Page 37: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/37.jpg)
CANCER NURSINGCANCER NURSING
GENERAL Promotive and Preventive Nursing GENERAL Promotive and Preventive Nursing ManagementManagement
1. Lifestyle Modification1. Lifestyle Modification 2. Nutritional management2. Nutritional management 3. Screening3. Screening 4. Early detection4. Early detection
![Page 38: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/38.jpg)
Nursing AssessmentNursing Assessment
Utilize the ACS 7 Warning SignalsUtilize the ACS 7 Warning Signals CAUTIONCAUTION C- Change in bowel/bladder habitsC- Change in bowel/bladder habits A- A sore that does not healA- A sore that does not heal U- Unusual bleedingU- Unusual bleeding T- Thickening or lump in the breastT- Thickening or lump in the breast I- IndigestionI- Indigestion O- Obvious change in wartsO- Obvious change in warts N- Nagging cough and hoarsenessN- Nagging cough and hoarseness
![Page 39: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/39.jpg)
SCREENINGSCREENING
1. Male and female- Occult Blood, CXR, and 1. Male and female- Occult Blood, CXR, and DREDRE
2. Female- SBE, CBE, Mammography and 2. Female- SBE, CBE, Mammography and Pap’s SmearPap’s Smear
3. Male- DRE for prostate, Testicular self-3. Male- DRE for prostate, Testicular self-examexam
![Page 40: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/40.jpg)
![Page 41: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/41.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
GENERAL MEDICAL MANAGEMENTGENERAL MEDICAL MANAGEMENT
- Treatment goals: cure, control and palliation- Treatment goals: cure, control and palliation 1. Surgery1. Surgery 2. Chemotherapy2. Chemotherapy 3. Radiation therapy3. Radiation therapy 4. Immunotherapy4. Immunotherapy 5. Bone Marrow Transplant5. Bone Marrow Transplant
![Page 42: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/42.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
SURGERYSURGERY Diagnostic- excision, incision, needleDiagnostic- excision, incision, needle primary method of treatment- local and wide primary method of treatment- local and wide
excisionexcision prophylacticprophylactic Palliative- relieve complications of CAPalliative- relieve complications of CA Reconstructive- improve function or obtain a Reconstructive- improve function or obtain a
more desirable cosmetic effectmore desirable cosmetic effect
![Page 43: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/43.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
NURSING MANAGEMENTNURSING MANAGEMENT Provide education and emotional supportProvide education and emotional support Assess patient’s responses to the surgeryAssess patient’s responses to the surgery Monitor for possible complications such as Monitor for possible complications such as
infection, bleeding, fluid and electrolyte infection, bleeding, fluid and electrolyte imbalance and organ dysfunctionimbalance and organ dysfunction
Plan for discharge, ff-up and home carePlan for discharge, ff-up and home care
![Page 44: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/44.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
RADIATION THERAPYRADIATION THERAPY Cure, control, prophylaxisCure, control, prophylaxis Cells are most vulnerable during DNA Cells are most vulnerable during DNA
synthesis and mitosis synthesis and mitosis (BM,lymphatic,skin,GIT,gonads)(BM,lymphatic,skin,GIT,gonads)
![Page 45: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/45.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
MAINTAIN TISSUE INTEGRITYMAINTAIN TISSUE INTEGRITY Frequently assess for changesFrequently assess for changes Handle skin gentlyHandle skin gently Do NOT rub affected areaDo NOT rub affected area Lotion may be applied (water-based)Lotion may be applied (water-based) Wash skin only with SOAP and WaterWash skin only with SOAP and Water During treatment period, avoid soap, creams, During treatment period, avoid soap, creams,
deodorants and powder on treatment areasdeodorants and powder on treatment areas
![Page 46: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/46.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
RISK FOR RADIATION INJURYRISK FOR RADIATION INJURY Protect caregivers fr exposure to radioactive Protect caregivers fr exposure to radioactive
implantsimplants Identify max time that can be spent safely Identify max time that can be spent safely
inpxs roominpxs room Use of shielding equipmentsUse of shielding equipments Explain to px the need for such precautions to Explain to px the need for such precautions to
keep px from feeling isolatedkeep px from feeling isolated
![Page 47: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/47.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
MANAGEMENT OF STOMATITISMANAGEMENT OF STOMATITIS Use soft-bristled toothbrush Use soft-bristled toothbrush Oral rinses with saline gargles/ tap waterOral rinses with saline gargles/ tap water Avoid ALCOHOL-based rinsesAvoid ALCOHOL-based rinses
![Page 48: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/48.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
CHEMOTHERAPYCHEMOTHERAPY Destroys tumor cells by interfering w/ cellular Destroys tumor cells by interfering w/ cellular
functions and reproductionfunctions and reproduction Used primarily to treat systemic disease rather Used primarily to treat systemic disease rather
than localized lesionsthan localized lesions
![Page 49: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/49.jpg)
![Page 50: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/50.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
ADMINISTRATION:ADMINISTRATION:Topical, Oral, IM, IV, Subcutaneous, arteria, Topical, Oral, IM, IV, Subcutaneous, arteria,
intracavitary, intrathecalintracavitary, intrathecalDosage based on TBSADosage based on TBSASpecial care needed for vesicants- causes Special care needed for vesicants- causes
extravasation (daunorubicin, doxorubicin, extravasation (daunorubicin, doxorubicin, nitrogen mustard, mitomycin, vincristine and nitrogen mustard, mitomycin, vincristine and vindesine. If suspected stop immediately and vindesine. If suspected stop immediately and apply ice except in vonca alkaloidapply ice except in vonca alkaloid
![Page 51: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/51.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
Common side effectsCommon side effects:: Nausea and vomiting,stomatitis, anorexia, Nausea and vomiting,stomatitis, anorexia,
diarrheadiarrhea MyelosuppressionMyelosuppression Nephrotoxicity-danorobucin, doxorubucinNephrotoxicity-danorobucin, doxorubucin CHF- cisplastin, methroxate, mitomycinCHF- cisplastin, methroxate, mitomycin Pulmonary fibrosis-bleomycin and busulfanPulmonary fibrosis-bleomycin and busulfan
![Page 52: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/52.jpg)
CANCER MANAGEMENTCANCER MANAGEMENT
SterilitySterility Reversible Neurologic damage- taxanes and Reversible Neurologic damage- taxanes and
plant alkaloids, peripheral neuropathy and plant alkaloids, peripheral neuropathy and hearing loss- cisplatinhearing loss- cisplatin
fatiguefatigue
![Page 53: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/53.jpg)
Nursing InterventionNursing Intervention
MANAGEMENT OF ALOPECIAMANAGEMENT OF ALOPECIAAlopecia begins within 2 weeks of therapyAlopecia begins within 2 weeks of therapy
Regrowth within 8 weeks of terminationRegrowth within 8 weeks of termination Encourage to acquire wig before hair loss Encourage to acquire wig before hair loss
occursoccurs Encourage use of attractive scarves and hatsEncourage use of attractive scarves and hats Provide information that hair loss is Provide information that hair loss is
temporary BUT anticipate change in texture temporary BUT anticipate change in texture and colorand color
![Page 54: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/54.jpg)
Nursing InterventionNursing Intervention
PROMOTE NUTRITIONPROMOTE NUTRITION Serve food in ways to make it appealingServe food in ways to make it appealing Consider patient’s preferencesConsider patient’s preferences Provide small frequent mealsProvide small frequent meals Avoids giving fluids while eatingAvoids giving fluids while eating Oral hygiene PRIOR to mealtimeOral hygiene PRIOR to mealtime Vitamin supplementsVitamin supplements
![Page 55: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/55.jpg)
Nursing InterventionNursing Intervention
RELIEVE PAINRELIEVE PAIN Mild pain- NSAIDSMild pain- NSAIDS
Moderate pain- Weak opiodsModerate pain- Weak opiods Severe pain- MorphineSevere pain- Morphine Administer analgesics round the clock with Administer analgesics round the clock with
additional dose for breakthrough painadditional dose for breakthrough pain
![Page 56: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/56.jpg)
Nursing InterventionNursing Intervention
DECREASE FATIGUEDECREASE FATIGUE Plan daily activities to allow alternating rest Plan daily activities to allow alternating rest
periodsperiods Light exercise is encouragedLight exercise is encouraged Small frequent mealsSmall frequent meals
![Page 57: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/57.jpg)
Nursing InterventionNursing Intervention
IMPROVE BODY IMAGEIMPROVE BODY IMAGE Therapeutic communication is essentialTherapeutic communication is essential Encourage independence in self-care and Encourage independence in self-care and
decision makingdecision making Offer cosmetic material like make-up and Offer cosmetic material like make-up and
wigswigs
![Page 58: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/58.jpg)
Nursing InterventionNursing Intervention
ASSIST IN THE GRIEVING PROCESSASSIST IN THE GRIEVING PROCESS Some cancers are curableSome cancers are curable Grieving can be due to loss of health, Grieving can be due to loss of health,
income, sexuality, and body imageincome, sexuality, and body image Answer and clarify information about Answer and clarify information about
cancer and treatment optionscancer and treatment options Identify resource peopleIdentify resource people Refer to support groupsRefer to support groups
![Page 59: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/59.jpg)
Nursing InterventionNursing Intervention
MANAGE COMPLICATION: MANAGE COMPLICATION: INFECTIONINFECTION
Fever is the most important sign (38.3)Fever is the most important sign (38.3) Administer prescribed antibiotics X 2weeksAdminister prescribed antibiotics X 2weeks Maintain aseptic technique Maintain aseptic technique Avoid exposure to crowds Avoid exposure to crowds Avoid giving fresh fruits and veggieAvoid giving fresh fruits and veggie HandwashingHandwashing Avoid frequent invasive proceduresAvoid frequent invasive procedures
![Page 60: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/60.jpg)
Nursing InterventionNursing Intervention
MANAGE COMPLICATION: Septic shockMANAGE COMPLICATION: Septic shock Monitor VS, BP, tempMonitor VS, BP, temp Administer IV antibioticsAdminister IV antibiotics Administer supplemental O2Administer supplemental O2
![Page 61: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/61.jpg)
Nursing InterventionNursing Intervention
MANAGE COMPLICATION: BleedingMANAGE COMPLICATION: Bleeding Thrombocytopenia (<100,000) is the most Thrombocytopenia (<100,000) is the most
common cause common cause <20, 000<20, 000 spontaneous bleeding spontaneous bleeding Use soft toothbrushUse soft toothbrush Use electric razorUse electric razor Avoid frequent IM, IV, rectal and Avoid frequent IM, IV, rectal and
catheterizationcatheterization Soft foods and stool softenersSoft foods and stool softeners
![Page 62: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/62.jpg)
![Page 63: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/63.jpg)
1. A chemotherapeutic agent was given to a 1. A chemotherapeutic agent was given to a patient as an adjunct to surgery .Which of the patient as an adjunct to surgery .Which of the following statements about chemotherapy is following statements about chemotherapy is true?true?
it is a local treatmentit is a local treatment it is affects both normal and cancer cellsit is affects both normal and cancer cells it is effective for all types of cancerit is effective for all types of cancer it has few adverse effectsit has few adverse effects
![Page 64: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/64.jpg)
2. A 30 y.o. client is about to receive chemotherapy. 2. A 30 y.o. client is about to receive chemotherapy. The nurse is monitoring the patient’s lab results prior The nurse is monitoring the patient’s lab results prior to the initiation of therapy. The nurse knows that the to the initiation of therapy. The nurse knows that the WBC count of the client is normal if the result WBC count of the client is normal if the result showedshowed
5,000-10,000 cells/mm35,000-10,000 cells/mm3 3,000- 7,000 cells/mm33,000- 7,000 cells/mm3 8,000-12,000 cells/mm38,000-12,000 cells/mm3 1,000-5,000 cells/mm31,000-5,000 cells/mm3
![Page 65: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/65.jpg)
3. Testicular self-examination is done as a 3. Testicular self-examination is done as a preventive screening procedure for testicular preventive screening procedure for testicular cancer. The right way to do the exam iscancer. The right way to do the exam is
examine the testes after a warm bath or showerexamine the testes after a warm bath or shower have the client examine his testes while lying have the client examine his testes while lying
supinesupine to feel for new growth or mass w/ 1 fingerto feel for new growth or mass w/ 1 finger to have an annual testicular exam doneto have an annual testicular exam done
![Page 66: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/66.jpg)
4. In health teaching done in the OB-gyne ward, 4. In health teaching done in the OB-gyne ward, the nurse instructs the clients to perform self-the nurse instructs the clients to perform self-breast examinationbreast examination
a week after the onset of menstruationa week after the onset of menstruation monthly during the peak of ovulationmonthly during the peak of ovulation at the start of menstruationat the start of menstruation 1 week before the onset of menstruation.1 week before the onset of menstruation.
![Page 67: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/67.jpg)
5. The following are examples of risk factors for 5. The following are examples of risk factors for cancer exceptcancer except
HPVHPV low-fat, high-fiber dietlow-fat, high-fiber diet radiation exposureradiation exposure Diethystilbestriol Diethystilbestriol
![Page 68: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/68.jpg)
6. A 54 y.o., G0, has been on conjugated 6. A 54 y.o., G0, has been on conjugated estrogen for 5 years. Among all the estrogen for 5 years. Among all the gynecologic cancers, Which one is she least gynecologic cancers, Which one is she least likely to acquire or have?likely to acquire or have?
Vaginal cancerVaginal cancer Breast cancerBreast cancer Ovarian cancerOvarian cancer Endometrial cancerEndometrial cancer
![Page 69: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/69.jpg)
7. Colorectal cancers are one of the most 7. Colorectal cancers are one of the most common type of cancers occurring in old age. common type of cancers occurring in old age. Screening for this type of cancer involves the Screening for this type of cancer involves the following exceptfollowing except
digital rectal examdigital rectal exam occult blood testing occult blood testing proctosigmoidoscopyproctosigmoidoscopy CT scanCT scan
![Page 70: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/70.jpg)
8. One of the clients in the ward has a family 8. One of the clients in the ward has a family history of colon cancer. The least appropriate history of colon cancer. The least appropriate advise for him would be toadvise for him would be to
have low fat, high fiber diethave low fat, high fiber diet to have an annual digital rectal exam to have an annual digital rectal exam to test for occult blood to test for occult blood have a colonoscopy done have a colonoscopy done
![Page 71: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/71.jpg)
9. Pap smear is a procedure done to screen for 9. Pap smear is a procedure done to screen for cervical cancer. As a preventive measure, this cervical cancer. As a preventive measure, this is ideally doneis ideally done
At the onset of sexual activity or at age 18At the onset of sexual activity or at age 18 annually for sexually active womenannually for sexually active women every other year for sexually active womenevery other year for sexually active women for women 20 yrs of age and above initially 2 for women 20 yrs of age and above initially 2
consecutive annual smear.consecutive annual smear.
![Page 72: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/72.jpg)
10. Testicular examination is advised as a screening 10. Testicular examination is advised as a screening procedure to detect testicular cancer. The client still procedure to detect testicular cancer. The client still needs further instructional reinforcements if he needs further instructional reinforcements if he verbalizedverbalized
a. “ The testicles are normally egg-shaped”a. “ The testicles are normally egg-shaped” b. “ My testicles feel smooth”b. “ My testicles feel smooth” c. “ My testicles normally has a spongy consistency”c. “ My testicles normally has a spongy consistency” d. “ This test is being done to detect any lumps”d. “ This test is being done to detect any lumps”
![Page 73: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/73.jpg)
Match the following type of viruses with Match the following type of viruses with the various type of tumor/malignancythe various type of tumor/malignancy
11. Nasopharyngeal cancer11. Nasopharyngeal cancer a. Epstein-Barr a. Epstein-Barr virusvirus
12. Non- hodgkins lymph0ma12. Non- hodgkins lymph0ma b. Hepatitis B b. Hepatitis B
13. Hepatocellular cancer13. Hepatocellular cancer c. Human c. Human Papilloma virusPapilloma virus
14. Burkitts lymphoma d. HTCLV14. Burkitts lymphoma d. HTCLV
15. Hodgkins disease15. Hodgkins disease
![Page 74: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/74.jpg)
Mortality and Morbidity RatesMortality and Morbidity Rates
![Page 75: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/75.jpg)
![Page 76: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/76.jpg)
Colon cancerColon cancer
![Page 77: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/77.jpg)
COLON CANCERCOLON CANCER
Risk factorsRisk factors 1. Increasing age1. Increasing age 2. Family history2. Family history 3. Previous colon CA or polyps3. Previous colon CA or polyps 4. History of IBD4. History of IBD 5. High fat, High protein, LOW fiber5. High fat, High protein, LOW fiber 6. Breast Ca and Genital Ca6. Breast Ca and Genital Ca
![Page 78: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/78.jpg)
COLON CANCERCOLON CANCER
Sigmoid colon is the most common siteSigmoid colon is the most common site Predominantly adenocarcinomaPredominantly adenocarcinoma If earlyIf early 90% survival 90% survival 34 % diagnosed early34 % diagnosed early 66% late diagnosis66% late diagnosis
![Page 79: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/79.jpg)
COLON CANCERCOLON CANCER
PATHOPHYSIOLOGYPATHOPHYSIOLOGY Benign neoplasmBenign neoplasm DNA alteration DNA alteration
malignant transformationmalignant transformation malignant malignant neoplasm neoplasm cancer growth and invasion cancer growth and invasion metastasis (liver)metastasis (liver)
![Page 80: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/80.jpg)
COLON CANCERCOLON CANCER
ASSESSMENT FINDINGSASSESSMENT FINDINGS1. 1. Change in bowel habits- Most commonChange in bowel habits- Most common
2. Blood in the stool2. Blood in the stool 3. Anemia3. Anemia 4. Anorexia and weight loss4. Anorexia and weight loss 5. Fatigue5. Fatigue 6. Rectal lesions- tenesmus, alternating D and C6. Rectal lesions- tenesmus, alternating D and C
![Page 81: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/81.jpg)
Colon cancerColon cancer
Diagnostic findingsDiagnostic findings 1. Fecal occult blood1. Fecal occult blood 2. Sigmoidoscopy and colonoscopy2. Sigmoidoscopy and colonoscopy 3. BIOPSY3. BIOPSY 4. CEA- carcino-embryonic antigen4. CEA- carcino-embryonic antigen
![Page 82: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/82.jpg)
Colon cancerColon cancer
Complications of colorectal CAComplications of colorectal CA 1. Obstruction1. Obstruction 2. Hemorrhage2. Hemorrhage 3. Peritonitis3. Peritonitis 4. Sepsis 4. Sepsis
![Page 83: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/83.jpg)
Colon cancerColon cancer
MEDICAL MANAGEMENTMEDICAL MANAGEMENT 1. Chemotherapy- 5-FU1. Chemotherapy- 5-FU 2. Radiation therapy2. Radiation therapy
![Page 84: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/84.jpg)
Colon cancerColon cancer
SURGICAL MANAGEMENTSURGICAL MANAGEMENT Surgery is the primary treatmentSurgery is the primary treatment Based on location and tumor sizeBased on location and tumor size Resection, anastomosis, and colostomy Resection, anastomosis, and colostomy
(temporary or permanent)(temporary or permanent)
![Page 85: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/85.jpg)
Colon cancerColon cancer
NURSING INTERVENTIONNURSING INTERVENTION
Pre-Operative carePre-Operative care 1. Provide HIGH protein, HIGH calorie and 1. Provide HIGH protein, HIGH calorie and
LOW residue dietLOW residue diet 2.Provide information about post-op care and 2.Provide information about post-op care and
stoma carestoma care 3. Administer antibiotics 1 day prior3. Administer antibiotics 1 day prior
![Page 86: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/86.jpg)
Colon cancerColon cancer
NURSING INTERVENTIONNURSING INTERVENTION
Pre-Operative carePre-Operative care 4. Enema or colonic irrigation the evening and 4. Enema or colonic irrigation the evening and
the morning of surgerythe morning of surgery 5. NGT is inserted to prevent distention5. NGT is inserted to prevent distention 6. Monitor UO, F and E, Abdomen PE6. Monitor UO, F and E, Abdomen PE
![Page 87: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/87.jpg)
Colon cancerColon cancer
NURSING INTERVENTIONNURSING INTERVENTION
Post-Operative carePost-Operative care 1. Monitor for complications1. Monitor for complications Leakage from the site, prolapse of stoma, skin Leakage from the site, prolapse of stoma, skin
irritation and pulmo complicationirritation and pulmo complication 2. Assess the abdomen for return of peristalsis2. Assess the abdomen for return of peristalsis
![Page 88: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/88.jpg)
Colon cancerColon cancer
NURSING INTERVENTIONNURSING INTERVENTION
Post-Operative carePost-Operative care 3. Assess wound dressing for bleeding3. Assess wound dressing for bleeding 4. Assist patient in ambulation after 24H4. Assist patient in ambulation after 24H 5.provide nutritional teaching5.provide nutritional teaching Limit foods that cause gas-formation and odorLimit foods that cause gas-formation and odor Cabbage, beans, eggs, fish, peanutsCabbage, beans, eggs, fish, peanuts Low-fiber diet in the early stage of recoveryLow-fiber diet in the early stage of recovery
![Page 89: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/89.jpg)
Colon cancerColon cancer
NURSING INTERVENTIONNURSING INTERVENTIONPost-Operative carePost-Operative care 6. Instruct to splint the incision and 6. Instruct to splint the incision and
administer pain meds before exerciseadminister pain meds before exercise 7. The stoma is PINKISH to cherry red, 7. The stoma is PINKISH to cherry red,
Slightly edematous with minimal pinkish Slightly edematous with minimal pinkish drainagedrainage
8. Manage post-operative complication8. Manage post-operative complication
![Page 90: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/90.jpg)
![Page 91: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/91.jpg)
Colon cancerColon cancer
NURSING INTERVENTION: COLOSTOMY NURSING INTERVENTION: COLOSTOMY CARECARE
Colostomy begins to function 3-6 days after Colostomy begins to function 3-6 days after surgerysurgery
The drainage maybe soft/mushy or semi-solid The drainage maybe soft/mushy or semi-solid depending on the sitedepending on the site
![Page 92: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/92.jpg)
Colon cancerColon cancer
NURSING INTERVENTION: COLOSTOMY NURSING INTERVENTION: COLOSTOMY CARECARE
BEST time to do skin care is after showerBEST time to do skin care is after shower Apply tape to the sides of the pouch before Apply tape to the sides of the pouch before
showershower Assume a sitting or standing position in Assume a sitting or standing position in
changing the pouchchanging the pouch
![Page 93: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/93.jpg)
Colon cancerColon cancer
NURSING INTERVENTION: COLOSTOMY NURSING INTERVENTION: COLOSTOMY CARECARE
Instruct to GENTLY push the skin down and Instruct to GENTLY push the skin down and the pouch pulling UPthe pouch pulling UP
Wash the peri-stomal area with soap and waterWash the peri-stomal area with soap and water Cover the stoma while washing the peri-stomal Cover the stoma while washing the peri-stomal
areaarea
![Page 94: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/94.jpg)
Colon cancerColon cancer
NURSING INTERVENTION: COLOSTOMY NURSING INTERVENTION: COLOSTOMY CARECARE
Lightly pat dry the area and NEVER rubLightly pat dry the area and NEVER rub Lightly dust the peri-stomal area with nystatin Lightly dust the peri-stomal area with nystatin
powderpowder
![Page 95: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/95.jpg)
Colon cancerColon cancer
NURSING INTERVENTION: COLOSTOMY NURSING INTERVENTION: COLOSTOMY CARECARE
Measure the stomal openingMeasure the stomal opening The pouch opening is about 0.3 cm larger than The pouch opening is about 0.3 cm larger than
the stomal openingthe stomal opening Apply adhesive surface over the stoma and Apply adhesive surface over the stoma and
press for 30 secondspress for 30 seconds
![Page 96: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/96.jpg)
Colon cancerColon cancer
NURSING INTERVENTION: COLOSTOMY NURSING INTERVENTION: COLOSTOMY CARECARE
Empty the pouch or change the pouch whenEmpty the pouch or change the pouch when 1/3 to ¼ full (Brunner)1/3 to ¼ full (Brunner) ½ to 1/3 full (Kozier)½ to 1/3 full (Kozier)
![Page 97: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/97.jpg)
1. Colostomy should be drained when it is1. Colostomy should be drained when it is A. fullA. full Half-fullHalf-full 100 ml full100 ml full As you wishAs you wish
![Page 98: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/98.jpg)
Pouch opening should be Pouch opening should be
A .3 cm larger than stomal openingA .3 cm larger than stomal opening
b. .5 cm larger than stomal openingb. .5 cm larger than stomal opening
c. 1 cm larger than stomal openingc. 1 cm larger than stomal opening
d. Same size with the openingd. Same size with the opening
![Page 99: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/99.jpg)
A client has underwent hemicolectomy and A client has underwent hemicolectomy and placement of Right colostomy. You expect the placement of Right colostomy. You expect the drainage to bedrainage to be
A. mushyA. mushy B. solidB. solid C. purely liquidC. purely liquid D. purely airD. purely air
![Page 100: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/100.jpg)
Most common manifestation of colon Ca isMost common manifestation of colon Ca is A. anemiaA. anemia B. tenesmusB. tenesmus C. alternating diarrhea and constipationC. alternating diarrhea and constipation D. painD. pain
![Page 101: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/101.jpg)
A client had a colostomy. When do You A client had a colostomy. When do You expect to note for fecal drainage?expect to note for fecal drainage?
A. as soon as the colostomy is placedA. as soon as the colostomy is placed B. 1 day afterB. 1 day after C. 3 days afterC. 3 days after D. 1 week after D. 1 week after
![Page 102: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/102.jpg)
All of the following are vesicants exceptAll of the following are vesicants except A. vincristineA. vincristine B. dopamycinB. dopamycin C. mustardC. mustard D.mitomycinD.mitomycin
![Page 103: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/103.jpg)
In patients receivne chemotherapy suspected In patients receivne chemotherapy suspected of extravasation, the drug must be stopped and of extravasation, the drug must be stopped and ice should be applied for all of the following ice should be applied for all of the following exceptexcept
A. vincristineA. vincristine B. doxorobucinB. doxorobucin C. mustardC. mustard D.mitomycinD.mitomycin
![Page 104: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/104.jpg)
A client receiving chemotherapy started to A client receiving chemotherapy started to complain of dyspnea. X-ray showed fibrosis. complain of dyspnea. X-ray showed fibrosis. Which of the following chemo agent is he Which of the following chemo agent is he most probably receiving?most probably receiving?
A. vinblastineA. vinblastine B. taxanesB. taxanes C. busulfanC. busulfan D. cisplatinD. cisplatin
![Page 105: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/105.jpg)
Cisplatin is known for causing which side Cisplatin is known for causing which side effecteffect
A. reversible hearing lossA. reversible hearing loss B. irreversible hearing lossB. irreversible hearing loss C. reversible peripheral neuropathyC. reversible peripheral neuropathy D. irreversible peripheral neuropathyD. irreversible peripheral neuropathy
![Page 106: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/106.jpg)
A client on chemotherapy started to complain A client on chemotherapy started to complain of dyspnea and orthopnea. Auscultation of dyspnea and orthopnea. Auscultation showed rales and crackles. Which of the showed rales and crackles. Which of the following drug is he most probably receiving?following drug is he most probably receiving?
A. chloramphenicolA. chloramphenicol B. vinblastineB. vinblastine C. busulfanC. busulfan D. cisplatinD. cisplatin
![Page 107: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/107.jpg)
Breast CancerBreast Cancer
The most common cancer in FEMALESThe most common cancer in FEMALES Numerous etiologies implicatedNumerous etiologies implicated
![Page 108: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/108.jpg)
![Page 109: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/109.jpg)
Breast CancerBreast Cancer
RISK FACTORSRISK FACTORS 1. Genetics- BRCA1 And BRCA 21. Genetics- BRCA1 And BRCA 2 2. Increasing age ( > 50yo)2. Increasing age ( > 50yo) 3. Family History of breast cancer3. Family History of breast cancer 4. Early menarche and late menopause4. Early menarche and late menopause 5. Nulliparity5. Nulliparity 6. Late age at pregnancy6. Late age at pregnancy
![Page 110: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/110.jpg)
Breast CancerBreast Cancer
RISK FACTORSRISK FACTORS 7. Obesity7. Obesity 8. Hormonal replacement8. Hormonal replacement 9. Alcohol9. Alcohol 10. Exposure to radiation10. Exposure to radiation
![Page 111: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/111.jpg)
Breast CancerBreast Cancer
PROTECTIVE FACTORSPROTECTIVE FACTORS 1. Exercise1. Exercise 2. Breast feeding2. Breast feeding 3. Pregnancy before 30 yo3. Pregnancy before 30 yo
![Page 112: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/112.jpg)
![Page 113: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/113.jpg)
Breast CancerBreast Cancer
ASSESSMENT FINDINGSASSESSMENT FINDINGS 1. MASS- the most common location is the 1. MASS- the most common location is the
upper outer quadrantupper outer quadrant 2. Mass is NON-tender. Fixed, hard with 2. Mass is NON-tender. Fixed, hard with
irregular bordersirregular borders 3. Skin dimpling3. Skin dimpling 4. Nipple retraction4. Nipple retraction 5. Peau d’ orange5. Peau d’ orange
![Page 114: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/114.jpg)
Breast CancerBreast Cancer
LABORATORY FINDINGSLABORATORY FINDINGS 1. Biopsy procedures1. Biopsy procedures 2. Mammography2. Mammography
![Page 115: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/115.jpg)
Breast CancerBreast Cancer
Breast cancer StagingBreast cancer Staging TNM stagingTNM staging I - < 2cmI - < 2cm II - 2 to 5 cm, (+) LNII - 2 to 5 cm, (+) LN III - > 5 cm, (+) LNIII - > 5 cm, (+) LN IV- metastasisIV- metastasis
![Page 116: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/116.jpg)
Breast CancerBreast Cancer
MEDICAL MANAGEMENTMEDICAL MANAGEMENT 1. Chemotherapy1. Chemotherapy 2. Tamoxifen therapy2. Tamoxifen therapy 3. Radiation therapy3. Radiation therapy
![Page 117: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/117.jpg)
Breast CancerBreast Cancer
SURGICAL MANAGEMENTSURGICAL MANAGEMENT1. Radical mastectomy1. Radical mastectomy
2. Modified radical mastectomy2. Modified radical mastectomy
3. Lumpectomy3. Lumpectomy
4. Quadrantectomy4. Quadrantectomy
![Page 118: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/118.jpg)
Breast CancerBreast CancerNURSING INTERVENTION : NURSING INTERVENTION : Post-OPPost-OP
Position patient: SupinePosition patient: Supine Affected extremity elevated to reduce edemaAffected extremity elevated to reduce edema Warm shower on 2Warm shower on 2ndnd day post-op day post-op Immediate post-op: snug dressing with drainageImmediate post-op: snug dressing with drainage Maintain patency of drain (JP) ; Drainage is Maintain patency of drain (JP) ; Drainage is
removed when the discharge is less than 30 ml in removed when the discharge is less than 30 ml in 24 H24 H
Monitor for hematoma w/in 12H and apply Monitor for hematoma w/in 12H and apply bandage and ice, refer to surgeonbandage and ice, refer to surgeon
![Page 119: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/119.jpg)
Breast CancerBreast Cancer
NURSING INTERVENTION : Post-OPNURSING INTERVENTION : Post-OP Lotions, Creams are applied ONLY when the Lotions, Creams are applied ONLY when the
incision is healed in 4-6 weeksincision is healed in 4-6 weeks Hand, shoulder exercise done on 2Hand, shoulder exercise done on 2ndnddayday Post-op mastectomy exercise 20 mins TIDPost-op mastectomy exercise 20 mins TID NO BP or IV procedure on operative siteNO BP or IV procedure on operative site Heavy lifting is avoidedHeavy lifting is avoided Monitor complications ( lymphedema, Monitor complications ( lymphedema,
hematoma, infecton)hematoma, infecton)
![Page 120: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/120.jpg)
Breast CancerBreast Cancer
NURSING INTERVENTION : Post-OPNURSING INTERVENTION : Post-OP
TEACH FOLLOW-UP careTEACH FOLLOW-UP care Regular check-upRegular check-up Monthly BSE on the other breastMonthly BSE on the other breast Annual mammographyAnnual mammography
![Page 121: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/121.jpg)
![Page 122: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/122.jpg)
Lung cancerLung cancer
66thth-7-7thth decade decade Number 1 in the morbidity and mortality Number 1 in the morbidity and mortality
survey among all cancerssurvey among all cancers Equal incidence for both men and womenEqual incidence for both men and women 85% caused by inhalation of carcinogenic 85% caused by inhalation of carcinogenic
materials most commonly cigarette smokingmaterials most commonly cigarette smoking
![Page 123: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/123.jpg)
Squamous cell carcinoma- more centrally Squamous cell carcinoma- more centrally located, commonly in the segmental and located, commonly in the segmental and subsegmental bronchi.subsegmental bronchi.
AdenoCarcinoma- presents more peripherally AdenoCarcinoma- presents more peripherally as peripheral mass or nodules; most prevalent as peripheral mass or nodules; most prevalent lung Ca for both M and Flung Ca for both M and F
Large cell carcinoma-fast growing tumor that Large cell carcinoma-fast growing tumor that arise peripherallyarise peripherally
![Page 124: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/124.jpg)
Bronchioalveolar cell CA- arises fr the Bronchioalveolar cell CA- arises fr the terminal bronchus and alveoli; usually slow terminal bronchus and alveoli; usually slow growinggrowing
Small cell Ca- arises primarily as a proximal Small cell Ca- arises primarily as a proximal lesion but may arise in any part of the lesion but may arise in any part of the tracheobronchial treetracheobronchial tree
![Page 125: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/125.jpg)
Lung CancerLung Cancer
EtiologyEtiology Tobacco useTobacco use Genetic- Genetic- >> acquired genetic lesion acquired genetic lesion
![Page 126: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/126.jpg)
Lung CancerLung Cancer
Clinical Manifestations:Clinical Manifestations: CoughCough HemoptysisHemoptysis Wheeze, stridorWheeze, stridor DyspneaDyspnea PneumonitisPneumonitis PainPain Symptoms of lung abscessSymptoms of lung abscess
![Page 127: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/127.jpg)
Lung CancerLung Cancer
Metastatic spread- tracheal obstruction, Metastatic spread- tracheal obstruction, dysphagia, hoarseness, Horner’s syndrome, dysphagia, hoarseness, Horner’s syndrome, auperior vena cava syndrome, plural effusion, auperior vena cava syndrome, plural effusion, respiratory failure.respiratory failure.
Systemic symptomsSystemic symptoms Endocrine syndromes-hypercalcemia Endocrine syndromes-hypercalcemia
(epidermoid), SIADH (sm cell), gynecomastia (epidermoid), SIADH (sm cell), gynecomastia (large cell), clubbing (non-sm. Cell)(large cell), clubbing (non-sm. Cell)
![Page 128: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/128.jpg)
Lung CancerLung Cancer
<5Any M0IV
<5Any T4 or N3,M0IIIB
25-4010-30
T3,N0-1,M0 T1-3,N2,M0
IIIA
25-50T1-2,N1,M0II
60-80T1-2,N0,M0I
5-yr survival rateTNM descriptorsStage
![Page 129: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/129.jpg)
Lung CancerLung Cancer
T1-< 3 cmT1-< 3 cmT2->3 cmT2->3 cmT3- direct extension into chest wallT3- direct extension into chest wallT4- invades mediastinumT4- invades mediastinumN0N0N1-peribronchialN1-peribronchialN2-ipsilateral mediastinalN2-ipsilateral mediastinalN3-contralateral mediastinalN3-contralateral mediastinal
![Page 130: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/130.jpg)
Lung CancerLung Cancer
TREATMENTTREATMENT Surgery (segmentectomy, lobectomy, Surgery (segmentectomy, lobectomy,
pneumonectomy)pneumonectomy) RadiotherapyRadiotherapy ChemotherapyChemotherapy
![Page 131: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/131.jpg)
![Page 132: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/132.jpg)
Laryngeal cancerLaryngeal cancer
Risk FactorsRisk Factors tobaccotobacco alcoholalcohol radiation?radiation? occupation?occupation?
![Page 133: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/133.jpg)
![Page 134: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/134.jpg)
CLASSIFICATION ACCORDING TO LOCATIONCLASSIFICATION ACCORDING TO LOCATION 1. supraglottic 1. supraglottic - rich in lymphatics- rich in lymphatics 2. glottic 2. glottic - (true vocal cords) most common 55-75%; good - (true vocal cords) most common 55-75%; good
prognosisprognosis 3. subglottic 3. subglottic - least common 1-5%; metastasizes to the - least common 1-5%; metastasizes to the
Delphian nodeDelphian node
![Page 135: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/135.jpg)
SYMPTOMS: SYMPTOMS: voice change- 2 wks durationvoice change- 2 wks duration airway obstructionairway obstruction odynophagiaodynophagia otalgiaotalgia neck massneck mass other constitutional symptomsother constitutional symptoms
![Page 136: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/136.jpg)
DIAGNOSIS:DIAGNOSIS: LARYNGOSCOPYLARYNGOSCOPY BIOPSYBIOPSY
![Page 137: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/137.jpg)
MANAGEMENTMANAGEMENT local excision/ vocal cord strippinglocal excision/ vocal cord stripping LASER vaporization or excision/ cordectomyLASER vaporization or excision/ cordectomy Radiotherapy Radiotherapy
(EBRT- external beam radiotherapy or (EBRT- external beam radiotherapy or brachytherapy – radioactive implants)brachytherapy – radioactive implants)
Conservation laryngectomy/ Total Conservation laryngectomy/ Total laryngectomylaryngectomy
![Page 138: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/138.jpg)
Laryngeal CancerLaryngeal CancerNURSING MANAGEMENT: PRE-operativeNURSING MANAGEMENT: PRE-operativeProvide the patient pre-operative teachingsProvide the patient pre-operative teachings Clarify misconceptionsClarify misconceptions Tell that the natural voice will be lostTell that the natural voice will be lost Teach communication alternativesTeach communication alternativesReduce patient ANXIETYReduce patient ANXIETY Provide opportunities for patient and family Provide opportunities for patient and family
members to ask questionsmembers to ask questions Referrals to previous patients with laryngeal Referrals to previous patients with laryngeal
cancers and cancer groups cancers and cancer groups
![Page 139: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/139.jpg)
Laryngeal CancerLaryngeal CancerNURSING MANAGEMENT: POST-opNURSING MANAGEMENT: POST-opMaintain PATENT AirwayMaintain PATENT Airway Position patient: Semi or High Fowler’sPosition patient: Semi or High Fowler’s Suction secretionsSuction secretions Encourage to deep breath, turn and coughEncourage to deep breath, turn and coughAdminister care of the laryngectomy tubeAdminister care of the laryngectomy tube Suction as neededSuction as needed Cleanse the stoma with salineCleanse the stoma with saline Administer humidified oxygenAdminister humidified oxygen Laryngectomy tube is usually removed within 3-6 Laryngectomy tube is usually removed within 3-6
weeks after surgeryweeks after surgery
![Page 140: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/140.jpg)
Laryngeal CancerLaryngeal CancerNURSING MANAGEMENT: POST-opNURSING MANAGEMENT: POST-op
Promote alternative communication methodsPromote alternative communication methods Call bell or hand bell, Magic Slate, Hand signalsCall bell or hand bell, Magic Slate, Hand signals Collaborate with speech therapistCollaborate with speech therapist
Promote adequate NutritionPromote adequate Nutrition NPO after operationNPO after operation No foods or drinks per orem for 10 daysNo foods or drinks per orem for 10 days IVF, TPN are alternative nutrition routesIVF, TPN are alternative nutrition routes Start oral feedings with thick liquids, avoid sweet Start oral feedings with thick liquids, avoid sweet
foodsfoods
![Page 141: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/141.jpg)
Laryngeal CancerLaryngeal CancerNURSING MANAGEMENT: POST-opNURSING MANAGEMENT: POST-op
Monitor for COMPLICATIONSMonitor for COMPLICATIONS Respiratory DistressRespiratory Distress HemorrhageHemorrhage infectioninfection
![Page 142: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/142.jpg)
Laryngeal CancerLaryngeal CancerNURSING MANAGEMENT: HOME CARENURSING MANAGEMENT: HOME CARE Humidification system at home is neededHumidification system at home is needed AVOID swimmingAVOID swimming Cover the stoma with hands or plastic bib over Cover the stoma with hands or plastic bib over
the openingthe opening Advise beauty salons to avoid hair sprays, Advise beauty salons to avoid hair sprays,
powders and loose hair near the openingpowders and loose hair near the opening Oral hygiene frequently Oral hygiene frequently
![Page 143: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/143.jpg)
![Page 144: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/144.jpg)
Prostate CancerProstate Cancer
EtiologyEtiology
Age-relatedAge-related
Blacks>whiteBlacks>white
95 % are adenocarcinomas95 % are adenocarcinomas
![Page 145: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/145.jpg)
Prostate CancerProstate Cancer
Manifestations:Manifestations: Rel. to urinary flow obstuctionRel. to urinary flow obstuction Urinary frequency, ec in caliber of stream, Urinary frequency, ec in caliber of stream,
diminished force, hesitancy, dribbling, diminished force, hesitancy, dribbling, nocturia and overflow incontinencenocturia and overflow incontinence
DysuriaDysuria Back or hip painBack or hip pain
![Page 146: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/146.jpg)
Prostate CancerProstate Cancer
DiagnosticsDiagnostics:: DREDRE PSA- PSA- >> 10 ng/ml 10 ng/ml Biopsy- transrectal prostate biopsy under Biopsy- transrectal prostate biopsy under
sonography (TRUS)sonography (TRUS)
![Page 147: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/147.jpg)
Prostate CancerProstate Cancer
TreatmentTreatment Surgery- radical retropubic prostatectomySurgery- radical retropubic prostatectomy Radiation therapyRadiation therapy
*both are associated w/ impotence*both are associated w/ impotence Androgen deprivation- for those w/ metastatic Androgen deprivation- for those w/ metastatic
disease (leuporide, flutamide)disease (leuporide, flutamide) Chemotherapy- for palliationChemotherapy- for palliation
![Page 148: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/148.jpg)
quizquiz
1. All of the following are manifestations of 1. All of the following are manifestations of prostate cancer exceptprostate cancer except
HesitancyHesitancy dribblingdribbling DysuriaDysuria Painless Painless
![Page 149: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/149.jpg)
2. The most common manifestation of 2. The most common manifestation of laryngeal cancer islaryngeal cancer is
A. odynophagiaA. odynophagia B. DysphagiaB. Dysphagia C. Voice changeC. Voice change D. dyspneaD. dyspnea
![Page 150: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/150.jpg)
3. Most head and neck cancers are caused by 3. Most head and neck cancers are caused by smoking. Which of the following is not caused smoking. Which of the following is not caused by smoking?by smoking?
A. lung cancerA. lung cancer B. ovarian CAB. ovarian CA C. laryngeal cancerC. laryngeal cancer D. esophageal cancerD. esophageal cancer
![Page 151: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/151.jpg)
QuizQuiz
4. a 64 y.o patient status post- hemi colectomy 4. a 64 y.o patient status post- hemi colectomy was tachycardic. Examination of the mucus was tachycardic. Examination of the mucus membrane showed a dry mouth. What is membrane showed a dry mouth. What is your assessment to the possible cause of your assessment to the possible cause of tachycardia in this patient?tachycardia in this patient?
infectioninfection 3rd spacing3rd spacing DehydrationDehydration sepsissepsis
![Page 152: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/152.jpg)
5. difference between a benign fr malignant 5. difference between a benign fr malignant neoplasm include all of the ff exceptneoplasm include all of the ff except
well differentiatedwell differentiated poorly demarcatedpoorly demarcated no metastatic potentialno metastatic potential non invasivenon invasive
![Page 153: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/153.jpg)
6. radiation therapy is effective in actively 6. radiation therapy is effective in actively dividing cells. All of the ff are ex of those dividing cells. All of the ff are ex of those exceptexcept
GITGIT Fatty tissuesFatty tissues NerveNerve skinskin
![Page 154: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/154.jpg)
7. screening should be done to detect cancers. 7. screening should be done to detect cancers. Routine Screening tests involves all of the Routine Screening tests involves all of the following exceptfollowing except breast exambreast exam DREDRE UltrasoundUltrasound Occult blood examOccult blood exam
![Page 155: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/155.jpg)
8. A client complained of chronic cough w/ 8. A client complained of chronic cough w/ hemoptysis. Assessment showed wasting, dry hemoptysis. Assessment showed wasting, dry skin and s/sxs of cachexia. The client most skin and s/sxs of cachexia. The client most probably hasprobably has
A. TBA. TB B. bronchiectasisB. bronchiectasis C. lung CAC. lung CA D. all of the aboveD. all of the above
![Page 156: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/156.jpg)
9. Client underwent pneumonectomy. Post-op 9. Client underwent pneumonectomy. Post-op the best position to put the client in isthe best position to put the client in is
a.a. Affected sideAffected side
b.b. Unaffected sideUnaffected side
c.c. TrendelenburgTrendelenburg
d.d. 10 inch block10 inch block
![Page 157: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/157.jpg)
10. Post-mastectomy lotions and cream may 10. Post-mastectomy lotions and cream may be applied after healing takes place. When be applied after healing takes place. When does it usually occur?does it usually occur?
A. 1 monthA. 1 month B. 2 monthsB. 2 months C. 4 monthsC. 4 months D. 1 yearD. 1 year
![Page 158: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/158.jpg)
Cervical CancerCervical Cancer peaks: 45-60 y.o.peaks: 45-60 y.o. Risk factors:Risk factors: Early coitusEarly coitus Early conceptionEarly conception Multiple sexual partnersMultiple sexual partners Cigarette smokingCigarette smoking High risk partnersHigh risk partners ImmunosuppressedImmunosuppressed HPVHPV HSVHSV
![Page 159: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/159.jpg)
Cervical cancerCervical cancer
Assessment:Assessment: post coital or irregular bleedingpost coital or irregular bleeding Malodorous bloody dischargeMalodorous bloody discharge SciaticaSciatica Leg edemaLeg edema Deep pelvic painDeep pelvic pain
![Page 160: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/160.jpg)
Treatment:Treatment: Surgery (radical hysterectomy)Surgery (radical hysterectomy) Radiotherapy ( external beam to the pelvis Radiotherapy ( external beam to the pelvis
followed by intracavitary)followed by intracavitary)
![Page 161: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/161.jpg)
Endometrial cancerEndometrial cancer Risk factors:Risk factors: 50-6050-60 ObesityObesity polycystic ovarian diseasepolycystic ovarian disease Early menarcheEarly menarche Late menopauseLate menopause Exogenous unopposed estrogenExogenous unopposed estrogen Tamoxifen( antiestrogen in breast but acts like estrogen in Tamoxifen( antiestrogen in breast but acts like estrogen in
the endometrium)the endometrium) Lynch II syndrome(hereditary nonpolyposis colorectal Lynch II syndrome(hereditary nonpolyposis colorectal
syndrome)syndrome)
![Page 162: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/162.jpg)
Assessment:Assessment: Irregular menses or postmenopausal bleedingIrregular menses or postmenopausal bleeding
Diagnosis: Diagnosis: D and CD and C
![Page 163: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/163.jpg)
Ovarian cancerOvarian cancer
Risk factors:Risk factors: Family historyFamily history Low parity and infertilityLow parity and infertility
![Page 164: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/164.jpg)
Assessment: Assessment: Abdominal distention- most commonAbdominal distention- most common Lower abdominal painLower abdominal pain Pelvic massPelvic mass Weight lossWeight loss
![Page 165: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/165.jpg)
Diagnostics:Diagnostics: Pelvic ultrasoundPelvic ultrasound CA-125CA-125 Abdominopelvic CT scan and chest Abdominopelvic CT scan and chest
radiography if suspected of having ovarian CAradiography if suspected of having ovarian CA
![Page 166: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/166.jpg)
Treatment:Treatment: SurgerySurgery Chemotherapy:Chemotherapy: Paclitaxel( neuropathy, Paclitaxel( neuropathy,
alopecia,myelosuppression,hypersensitivity alopecia,myelosuppression,hypersensitivity and bradycardia)and bradycardia)
Carboplatin ( N/V, myelosuppression, Carboplatin ( N/V, myelosuppression, constipation)constipation)
![Page 167: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/167.jpg)
Non-Hodgkins LymphomaNon-Hodgkins Lymphoma
Heterogenous group of cancersHeterogenous group of cancers Originates from neoplastic growth of Originates from neoplastic growth of
lymphoid tissuelymphoid tissue Mostly involves malignant B lymphocytes; Mostly involves malignant B lymphocytes;
only 5% only 5% are T lymphocytesare T lymphocytes
![Page 168: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/168.jpg)
Non-Hodgkins LymphomaNon-Hodgkins Lymphoma
Manifestations:Manifestations: Symptoms are highly variableSymptoms are highly variable Symptoms may be absent or very minimal at the Symptoms may be absent or very minimal at the
early-stage of the diseaseearly-stage of the disease Typically diagnosed at a latter stage when px is more Typically diagnosed at a latter stage when px is more
symptomatic; lymphadenopathy is noticeable (stages symptomatic; lymphadenopathy is noticeable (stages III or IV)III or IV)
1/3 of cases have “B symptoms” (recurrent fever, 1/3 of cases have “B symptoms” (recurrent fever, drenching night sweats, & unintentional wt. loss of drenching night sweats, & unintentional wt. loss of >10%>10%
![Page 169: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/169.jpg)
Non-Hodgkins LymphomaNon-Hodgkins Lymphoma
Assessment & DiagnosticsAssessment & Diagnostics HistopathologyHistopathology ImmunophenotypingImmunophenotyping Cytogenetic analysisCytogenetic analysis
Staging – based on data obtained from CT Staging – based on data obtained from CT scan, bone marrow biopsies, CSF analysisscan, bone marrow biopsies, CSF analysis
![Page 170: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/170.jpg)
Non-Hodgkins LymphomaNon-Hodgkins Lymphoma
Treatment:Treatment: based on actual classification & stage of disease, prior based on actual classification & stage of disease, prior
treatment, & px’s ability to tolerate therapytreatment, & px’s ability to tolerate therapy Radiation alone maybe beneficial in localized non-Radiation alone maybe beneficial in localized non-
aggressive formsaggressive forms In aggressive types, combination chemotherapy are In aggressive types, combination chemotherapy are
given in early stagesgiven in early stages Intermediate forms – chemotherapy + radiotherapy Intermediate forms – chemotherapy + radiotherapy
for st. I & II diseasefor st. I & II disease
![Page 171: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/171.jpg)
lymphomalymphoma
Hodgkins diseaseHodgkins disease Cause: unknownCause: unknown S/sxs: painless lymphadenopathy, *reed S/sxs: painless lymphadenopathy, *reed
sternberg cell, edema(lymph sternberg cell, edema(lymph obstuction),cough,dypnea(mediastinal node obstuction),cough,dypnea(mediastinal node enlargment)enlargment)
Mgt: radio,chemo (MOPP), Mgt: radio,chemo (MOPP), supportive,splenectomysupportive,splenectomy
![Page 172: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/172.jpg)
Urinary bladder CancerUrinary bladder Cancer
ETIOLOGY AND RISK FACTORSETIOLOGY AND RISK FACTORS 65 Yrs.- median age65 Yrs.- median age SmokingSmoking Cyclophosphamide exposureCyclophosphamide exposure Schistoma haematobiumSchistoma haematobium
![Page 173: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/173.jpg)
Urinary bladder CancerUrinary bladder Cancer
ManifestationsManifestations:: Hematuria- mOst common symptomHematuria- mOst common symptom Urinary changes may accompany laterUrinary changes may accompany later Usually asymptomatic at early stagesUsually asymptomatic at early stages
![Page 174: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/174.jpg)
Diagnosis:Diagnosis: Urinalysis- hematuriaUrinalysis- hematuria IVP- decreased bladder fillingIVP- decreased bladder filling Cystoscopy- diagnosticCystoscopy- diagnostic
![Page 175: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/175.jpg)
Urinary bladder CancerUrinary bladder Cancer
Treatment:Treatment: Based on extent of diseaseBased on extent of disease Surgical ResectionSurgical Resection Intravesical chemotherapyIntravesical chemotherapy
![Page 176: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/176.jpg)
Skin cancerSkin cancer
EtiologyEtiology : :– – chronic friction, irritation & exposure to UVchronic friction, irritation & exposure to UV
TypesTypes::1. basal cell – most common1. basal cell – most common2. squamous cell 2. squamous cell 3. malignant melanoma – most fatal3. malignant melanoma – most fatal
![Page 177: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/177.jpg)
Squamous cell CarcinomaSquamous cell Carcinoma
Risk factors:Risk factors: UV raysUV rays RadiationRadiation Actinic keratosisActinic keratosis ImmunosuppressionImmunosuppression Industrial carcinogensIndustrial carcinogens
![Page 178: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/178.jpg)
Squamous cell CarcinomaSquamous cell Carcinoma
History and Assessment:History and Assessment: Slowly evolvingSlowly evolving AssymptomaticAssymptomatic Occassionaly bleeding and painOccassionaly bleeding and pain Exophytic nodules w/ varying degree of Exophytic nodules w/ varying degree of
scaling or crustingscaling or crusting
![Page 179: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/179.jpg)
![Page 180: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/180.jpg)
![Page 181: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/181.jpg)
Basal Cell CarcinomaBasal Cell Carcinoma
Risk factors:Risk factors: UV raysUV rays May take several forms: nodular, ulcerative, May take several forms: nodular, ulcerative,
pigmented ad superficial pigmented ad superficial
![Page 182: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/182.jpg)
Basal Cell CarcinomaBasal Cell Carcinoma
Hx and Assessment:Hx and Assessment: Usually asymptomatic unless secondarily Usually asymptomatic unless secondarily
infected in advanced diseaseinfected in advanced disease Pearly-colored PAPULE Pearly-colored PAPULE External surface - fine telangiectasia and is External surface - fine telangiectasia and is
translucenttranslucent
![Page 183: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/183.jpg)
![Page 184: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/184.jpg)
MelanomaMelanoma
Risk factors:Risk factors: Sun exposureSun exposure Fair skinFair skin Positive family historyPositive family history Presence of dysplastic neviPresence of dysplastic nevi
![Page 185: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/185.jpg)
MelanomaMelanomaHx and Assessment:Hx and Assessment: Usually asymptomatic until lateUsually asymptomatic until late Pruritus or mild discomfortPruritus or mild discomfort Recent changed in a previous skin lesionRecent changed in a previous skin lesion A- asymetryA- asymetry B- border irregularityB- border irregularity C- color variationC- color variation D- diameter(large)D- diameter(large)
![Page 186: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/186.jpg)
![Page 187: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/187.jpg)
Skin CancerSkin Cancer
InterventionsInterventions: :
preventive measurespreventive measuresa.a. monitoring of any lesionmonitoring of any lesion
b.b. have moles or lesions removed if they are subject have moles or lesions removed if they are subject to chronic irritationto chronic irritation
c.c. avoid contact with chemical irritantsavoid contact with chemical irritants
d.d. use of sunscreenuse of sunscreen
e.e. avoid too much sun exposureavoid too much sun exposure
![Page 188: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/188.jpg)
Hepatocellular CAHepatocellular CA
Hepa BHepa B alcoholalcohol
![Page 189: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/189.jpg)
![Page 190: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/190.jpg)
Liver physiology and Liver physiology and PathophysiologyPathophysiology
= Gynecomastia, testes atrophy8. Metabolizes estrogen
=Deficiencies of Vit and min7. Stores Vit and minerals
=Hyperammonemia6. Converts ammonia to urea
= Jaundice & pruritus5. Secreting bile
= Bleeding tendencies4. Synthesizes Clotting factors
=Decreased Antibody formation3. Synthesizes globulins
= Hypoproteinemia2. Synthesizes proteins
= Hypoglycemia1. Stores glycogen
Abnormality in functionNormal Function
![Page 191: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/191.jpg)
CONDITION OF THE LIVERCONDITION OF THE LIVER
NURSING INTERVENTIONSNURSING INTERVENTIONS 1. Monitor VS, I and O, Abdominal 1. Monitor VS, I and O, Abdominal
girth, weight, LOC and Bleedinggirth, weight, LOC and Bleeding 2. Promote rest. Elevated the head 2. Promote rest. Elevated the head
of the bed to minimize dyspneaof the bed to minimize dyspnea
![Page 192: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/192.jpg)
CONDITION OF THE LIVERCONDITION OF THE LIVER
NURSING INTERVENTIONSNURSING INTERVENTIONS 3. Provide Moderate to LOW-protein (1 g/kg/day) 3. Provide Moderate to LOW-protein (1 g/kg/day)
and LOW-sodium dietand LOW-sodium diet 4. Provide supplemental vitamins (especially K) 4. Provide supplemental vitamins (especially K)
and mineralsand minerals Administer prescribedAdminister prescribedDiuretics= to reduce ascites and edemaDiuretics= to reduce ascites and edemaLactulose= to reduce NH4 in the bowelLactulose= to reduce NH4 in the bowelAntacids and Neomycin= to kill bacterial flora that Antacids and Neomycin= to kill bacterial flora that
cause NH productioncause NH production
![Page 193: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/193.jpg)
CONDITION OF THE LIVERCONDITION OF THE LIVER
NURSING INTERVENTIONSNURSING INTERVENTIONS6. Avoid hepatotoxic drugs6. Avoid hepatotoxic drugs
ParacetamolParacetamol Anti-tubercular drugsAnti-tubercular drugs
7. Reduce the risk of injury 7. Reduce the risk of injury Side rails reorientationSide rails reorientation Assistance in ambulationAssistance in ambulation Use of electric razor and soft-bristled Use of electric razor and soft-bristled
toothbrushtoothbrush
![Page 194: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/194.jpg)
CONDITION OF THE LIVERCONDITION OF THE LIVER
NURSING INTERVENTIONSNURSING INTERVENTIONS 8. Keep equipments ready including 8. Keep equipments ready including
Sengstaken-Blakemore tube, IV fluids, Sengstaken-Blakemore tube, IV fluids, Medications to treat hemorrhageMedications to treat hemorrhage
9. Assist in surgery and chemotherapy9. Assist in surgery and chemotherapy
![Page 195: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/195.jpg)
1. What is the most common manifestation of 1. What is the most common manifestation of urinary bladder cancer?urinary bladder cancer?
A. pelvic painA. pelvic pain B. Painful hematuriaB. Painful hematuria C. painless heamturiaC. painless heamturia D. pelvic mass D. pelvic mass
![Page 196: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/196.jpg)
2. In patient w/ liver disorders, they are given 2. In patient w/ liver disorders, they are given drugs drugs to kill bacterial flora that cause NH to kill bacterial flora that cause NH production. Which of the following drugs production. Which of the following drugs serves that purpose?serves that purpose?
a.a. VancomycinVancomycin
b.b. AmoxicillinAmoxicillin
c.c. NeomycinNeomycin
d.d. Nitrogen mustardNitrogen mustard
![Page 197: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/197.jpg)
3. Cervical cancer is fast growing. This is 3. Cervical cancer is fast growing. This is associated w/ all of the following exceptassociated w/ all of the following except
A. HPVA. HPV B. herpes simplexB. herpes simplex C. genital wartsC. genital warts D. HTLVD. HTLV
![Page 198: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/198.jpg)
4. Prolonged Exposure to estrogen increases the 4. Prolonged Exposure to estrogen increases the risk for acquiring All of the following types of risk for acquiring All of the following types of cancer exceptcancer except
a.a. Breast CABreast CA
b.b. Ovarian CAOvarian CA
c.c. Endometrial CaEndometrial Ca
d.d. Ductal CADuctal CA
![Page 199: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/199.jpg)
5. Malignant melanoma is often seen in fair 5. Malignant melanoma is often seen in fair skinned individuals. Assessment findings skinned individuals. Assessment findings which will help strenthen the diagnosis which will help strenthen the diagnosis includesincludes
A- asymetryA- asymetry B- border irregularityB- border irregularity C- color variationC- color variation D- diameter (small)D- diameter (small)
![Page 200: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/200.jpg)
6. All of the following are correct except6. All of the following are correct except A. melanoma- assymetricalA. melanoma- assymetrical B. squamous CA- ulceratingB. squamous CA- ulcerating C. basal cell- pearly colored papuleC. basal cell- pearly colored papule D. Squamous cell- nodularD. Squamous cell- nodular
![Page 201: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/201.jpg)
7. Lymphoma is a malignancy involving the 7. Lymphoma is a malignancy involving the lymph tissues. The most common lymph node lymph tissues. The most common lymph node involved isinvolved is
a.a. CervicalCervical
b.b. SupraclavicularSupraclavicular
c.c. MediastinalMediastinal
d.d. inguinalinguinal
![Page 202: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/202.jpg)
8. Which of the following assessment findings 8. Which of the following assessment findings will aid you in diagnosisng hodgkin’s diseasewill aid you in diagnosisng hodgkin’s disease
A. lymphadenopathyA. lymphadenopathy B. hematuriaB. hematuria C. reed sternberg cellC. reed sternberg cell D. lymphedemaD. lymphedema
![Page 203: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/203.jpg)
9. Patients w/ cervical cancer often complains of9. Patients w/ cervical cancer often complains of
a.a. DysmenorrheaDysmenorrhea
b.b. Post coital bleedingPost coital bleeding
c.c. Pelvic massPelvic mass
d.d. Pelvic painPelvic pain
![Page 204: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/204.jpg)
10. Patients with liver cancer often presents with 10. Patients with liver cancer often presents with following assessment findings exceptfollowing assessment findings except
a.a. Esophageal varicesEsophageal varices
b.b. AscitesAscites
c.c. HyperglycemiaHyperglycemia
d.d. Petechiae and echymosisPetechiae and echymosis
![Page 205: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/205.jpg)
![Page 206: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/206.jpg)
![Page 207: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/207.jpg)
5. chemotherapy was advised in a patient 5. chemotherapy was advised in a patient diagnosed w/ skin Cancer. Vinblistine was the diagnosed w/ skin Cancer. Vinblistine was the agent ordered. You know that vinblistine is a agent ordered. You know that vinblistine is a vesicant type of agent and causes vesicant type of agent and causes extravasationextravasation intravasationintravasation nephrotoxicitynephrotoxicity ototoxicityototoxicity
![Page 208: Oncology Nursing](https://reader036.vdocuments.mx/reader036/viewer/2022081413/5472b566b4af9f18338b4629/html5/thumbnails/208.jpg)
6. Most frequent cause of fever w/in 24 hrs in a 6. Most frequent cause of fever w/in 24 hrs in a post-op patient is….post-op patient is….
7-9. internal Radiation therapy poses a risk for 7-9. internal Radiation therapy poses a risk for both patient and caregiver. Give 3 ways to both patient and caregiver. Give 3 ways to avoid unnecessary exposureavoid unnecessary exposure
10. Most common manifestation of lung cancer 10. Most common manifestation of lung cancer in early stages is…..in early stages is…..